Prescription Drug Price Relief Act of 2025

This bill would require the Department of Health and Human Services to check the prices of brand-name drugs every year to see if they are too high. A drug's price is considered too high if it costs more in the United States than the middle price charged in Canada, the United Kingdom, Germany, France, and Japan, or if the price is unreasonable based on things like how much it cost to develop and how much money it has already made. If a drug is found to be priced too high, the government would take away the company's exclusive rights to sell it, allow other companies to make cheaper generic versions, and speed up the approval process for those generic versions. The bill would also require drug companies to publicly report financial details like how much they spend on research and advertising.

Your Vote